DHPA submitted a letter to the leadership of the U.S. Senate Finance Committee expressing concerns about Section 102 of the Prescription Drug Pricing Reduction Act (PDPRA) of 2019, which was recently marked up by the Committee.
The Digestive Health Physicians Association (DHPA) and a broad coalition of 29 physician groups voiced strong opposition to H.R. 2143, legislation that would eliminate the in-office ancillary services exception (IOASE) and make it harder for physicians to coordinate care for their patients.
DHPA and 26 additional physician groups voiced strong support for S.966, the Medicare Care Coordination Improvement Act of 2019, bipartisan legislation that would substantially improve care coordination for patients, improve health outcomes and restrain costs by allowing physicians to participate and succeed in alternative payment models.
DHPA submitted comments in response to a Request for Information (RFI) from the Office of Inspector General (OIG) in the U.S. Department of Health and Human Services regarding the need to modernize the Anti-Kickback Statute. DHPA’s comment letter complements another set of comments submitted to CMS which focused on modernizing the Stark law to remove […]
DHPA joined a coalition of 240 patient and provider groups signing onto a letter to U.S. Senate and U.S. House leaders asking them to urge the Centers for Medicare & Medicaid Services (CMS) to reconsider a proposal to allow Medicare Advantage plans to implement step therapy to manage Part B drugs. CMS originally announced the […]